176 related articles for article (PubMed ID: 3774085)
1. [Plasma binding of drugs in chronic renal failure].
Riant P; Barre J; Albengres E; Lemaire M; Tillement JP
Nephrologie; 1986; 7(3):89-93. PubMed ID: 3774085
[TBL] [Abstract][Full Text] [Related]
2. Effects of the oral adsorbent AST-120 on tryptophan metabolism in uremic patients.
Tsubakihara Y; Takabatake Y; Oka K; Shoji T; Togawa M; Okada N; Takahito I; Imai E
Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S38-41. PubMed ID: 12612950
[TBL] [Abstract][Full Text] [Related]
3. Elimination and serum protein binding of phenylbutazone in patients with renal insufficiency.
Held H; Enderle C
Clin Nephrol; 1976 Sep; 6(3):388-93. PubMed ID: 136326
[TBL] [Abstract][Full Text] [Related]
4. [Factors of variation in plasma protein binding of drugs in patients with chronic renal failure].
Riant P; Bree F; Morin D; Barre J; Tillement JP
Therapie; 1987; 42(6):507-10. PubMed ID: 3441893
[No Abstract] [Full Text] [Related]
5. In-vitro study on the competitive binding of diflunisal and uraemic toxins to serum albumin and human plasma using a potentiometric ion-probe technique.
Davilas A; Koupparis M; Macheras P; Valsami G
J Pharm Pharmacol; 2006 Nov; 58(11):1467-74. PubMed ID: 17132209
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of hepatic cirrhosis on the plasma protein binding of drugs.
García-Morillas M; Gil-Extremera B; Caracuel-Ruiz MD
Int J Clin Pharmacol Res; 1984; 4(5):327-33. PubMed ID: 6519849
[TBL] [Abstract][Full Text] [Related]
7. Binding of drugs to human serum albumin:XI. The specificity of three binding sites as studied with albumin immobilized in microparticles.
Sjöholm I; Ekman B; Kober A; Ljungstedt-Påhlman I; Seiving B; Sjödin T
Mol Pharmacol; 1979 Nov; 16(3):767-77. PubMed ID: 530258
[No Abstract] [Full Text] [Related]
8. [Characteristics of the pharmacokinetics of drugs in renal failure].
Nadzhimutdinov KN; Krakovskiĭ ME
Farmakol Toksikol; 1985; 48(5):109-13. PubMed ID: 3908139
[No Abstract] [Full Text] [Related]
9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
10. Plasma protein binding of drugs and adjustment of their dosing regimen in patients with chronic renal failure.
Schück O
Int J Clin Pharmacol Ther Toxicol; 1987 Sep; 25(9):476-8. PubMed ID: 3679618
[TBL] [Abstract][Full Text] [Related]
11. Protein binding of itraconazole and fluconazole in patients with chronic renal failure.
Arredondo G; Martinez-Jorda R; Calvo R; Aguirre C; Suarez E
Int J Clin Pharmacol Ther; 1994 Jul; 32(7):361-4. PubMed ID: 7952798
[TBL] [Abstract][Full Text] [Related]
12. An analysis of the effect of hypoalbuminemia on the amount of free drug in plasma for drugs bound at two sets of sites.
Wosilait WD
Res Commun Chem Pathol Pharmacol; 1974 Dec; 9(4):681-8. PubMed ID: 4456500
[No Abstract] [Full Text] [Related]
13. Drug protein interaction: displacement of albumin bound 8-methoxypsoralen by drugs.
Bevilacqua R; Benassi CA; Schiavon O; Veronese FM
Farmaco Sci; 1981 Jul; 36(7):598-605. PubMed ID: 7274442
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics in patients with renal failure.
Maher JF
Clin Nephrol; 1984 Jan; 21(1):39-46. PubMed ID: 6368069
[TBL] [Abstract][Full Text] [Related]
15. New aspects of free drug concentration determination in human serum with equilibrium dialysis.
van der Giesen WF; Wilting J
Methods Find Exp Clin Pharmacol; 1982; 4(6):417-23. PubMed ID: 7144334
[TBL] [Abstract][Full Text] [Related]
16. Plasma tryptophan level in chronic renal failure.
Cernácek P; Becvárová H; Gerová Z; Válek A; Spustová V
Clin Nephrol; 1980 Nov; 14(5):246-9. PubMed ID: 7226582
[TBL] [Abstract][Full Text] [Related]
17. Characterization of drug-protein binding process by employing equilibrium sampling through hollow-fiber supported liquid membrane and Bjerrum and Scatchard plots.
Barri T; Trtić-Petrović T; Karlsson M; Jönsson JA
J Pharm Biomed Anal; 2008 Sep; 48(1):49-56. PubMed ID: 18565712
[TBL] [Abstract][Full Text] [Related]
18. Cortisol binding in uremic plasma. II. Decreased cortisol binding to albumin.
Rosman PM; Benn R; Kay M; Wallace EZ
Nephron; 1984; 37(4):229-31. PubMed ID: 6462312
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro.
Olsen H; Andersen A; Nordbø A; Kongsgaard UE; Børmer OP
BMC Clin Pharmacol; 2004 Mar; 4():4. PubMed ID: 15046641
[TBL] [Abstract][Full Text] [Related]
20. [When is determination of drug concentrations in plasma useful or necessary?].
Roots I
Internist (Berl); 1986 Jan; 27(1):40-52. PubMed ID: 3514516
[No Abstract] [Full Text] [Related]
[Next] [New Search]
